UnknownPhase 2/3

Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial.

Egypt92 participantsStarted 2023-10-01

Plain-language summary

The goal of this prospective randomized controlled study is to study the safety and efficacy of intralesional acyclovir compared to cryotherapy in plantar warts. The main questions needed to be answered are: 1. Is Intralesional acyclovir safe for plantar warts? 2. Is Intralesional acyclovir more efficient in treating plantar warts compared to cryotherapy?

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 18 years or older, of both genders, with plantar warts Exclusion Criteria: * Patients on systemic treatment for warts eg. Acitretin, Acyclovir * Hypersensitivity to Acyclovir * Previous treatment to the same wart during the last 3 months * Immunocompromised patients (as HIV, steroid intake, uncontrolled diabetes, etc.) * Pregnant and breastfeeding females * Cognitively impaired patients

What they're measuring

Cure rate

Timeframe: 10 weeks (5 sessions max)

Recurrence rate

Timeframe: 24 weeks

Patient satisfaction score

Timeframe: 10 weeks

Trial details

NCT IDNCT06261684

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-01

Contact for this trial

Basant Helal, MRCP

+201144166922 basant_helal@hotmail.com

View on ClinicalTrials.gov More Plantar Wart trials